Trial Site Detail
Drug: |
XL820 |
|||
|---|---|---|---|---|
Trial: |
A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
Oncology Specialists, Park Ridge1700 Luther Ln |
Principal Investigator: |
Pamela Kaiser, M.D. |
|---|---|
Contact: |
Kathy Tolzein, RN, 847 268-8200 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Oncology Specialists, Park Ridge Website: |
http://www.oncmed.net/index.html |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.